• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Th1、Th2和Th17细胞因子与甲状腺相关性眼病的关系

Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.

作者信息

Shen Jie, Li Zhangfang, Li Wenting, Ge Ying, Xie Min, Lv Meng, Fan Yanfei, Chen Zhi, Zhao Defu, Han Yajuan

机构信息

Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China.

Department of Endocrinology and Metabolism, Guangzhou City People's Hospital, Huadu District, Guangzhou, China.

出版信息

Dis Markers. 2015;2015:609593. doi: 10.1155/2015/609593. Epub 2015 May 18.

DOI:10.1155/2015/609593
PMID:26089587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4451372/
Abstract

To determine serum cytokine profiles in Graves' disease (GD) patients with or without active and inactive thyroid associated ophthalmopathy (TAO), we recruited 65 subjects: 10 GD only (without TAO), 25 GD + active TAO, 20 GD + TAO, and 10 healthy controls. Liquid chip assay was used to measure serum Th1/Th2/Th17 cytokines including IFN-γ (interferon-gamma), TNF-α (tumor necrosis factor-alpha), IL-1α (interleukin-1 alpha), IL-1Ra (IL-1 receptor antagonist), IL-2, IL-4, IL-6, and IL-17 and two chemokines: RANTES (regulated upon activation, normal T cell expressed and secreted) and IP-10 (IFN-γ-induced protein 10). Serum levels of TSH (thyroid stimulating hormone) receptor autoantibodies (TRAb) were measured using an enzyme linked immunosorbent assay. Compared with healthy controls, TAO patients showed significantly elevated serum levels of IFN-γ, TNF-α, IL-1α, IL-4, IL-6, IL-17, and IP-10. Comparing active and inactive TAO, serum Th1 cytokines IFN-γ and TNF-α were elevated in active TAO, while serum Th2 cytokine IL-4 was elevated in inactive TAO. Serum Th17 cytokine IL-17 was elevated in GD but reduced in both active and inactive TAO. A positive correlation was found between TRAb and IFN-γ, TNF-α, IL-1α, IL-2, IL-4, and IL-6. Taken together, serum Th1/Th2/Th17 cytokines and chemokines reflect TAO disease activity and may be implicated in TAO pathogenesis.

摘要

为了确定伴有或不伴有活动期和静止期甲状腺相关眼病(TAO)的格雷夫斯病(GD)患者的血清细胞因子谱,我们招募了65名受试者:10名仅患有GD(无TAO)、25名GD + 活动期TAO、20名GD + TAO以及10名健康对照。采用液相芯片分析法检测血清Th1/Th2/Th17细胞因子,包括干扰素-γ(IFN-γ)、肿瘤坏死因子-α(TNF-α)、白细胞介素-1α(IL-1α)、白细胞介素-1受体拮抗剂(IL-1Ra)、白细胞介素-2、白细胞介素-4、白细胞介素-6和白细胞介素-17,以及两种趋化因子:活化正常T细胞表达和分泌的调节因子(RANTES)和干扰素-γ诱导蛋白10(IP-10)。采用酶联免疫吸附测定法检测血清促甲状腺激素(TSH)受体自身抗体(TRAb)水平。与健康对照相比,TAO患者血清中IFN-γ、TNF-α、IL-1α、IL-4、IL-6、IL-17和IP-10水平显著升高。比较活动期和静止期TAO,活动期TAO患者血清Th1细胞因子IFN-γ和TNF-α升高,而静止期TAO患者血清Th2细胞因子IL-4升高。血清Th17细胞因子IL-17在GD患者中升高,但在活动期和静止期TAO患者中均降低。发现TRAb与IFN-γ、TNF-α、IL-1α、IL-2、IL-4和IL-6之间呈正相关。综上所述,血清Th1/Th2/Th17细胞因子和趋化因子反映了TAO的疾病活动,可能参与了TAO的发病机制。

相似文献

1
Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.Th1、Th2和Th17细胞因子与甲状腺相关性眼病的关系
Dis Markers. 2015;2015:609593. doi: 10.1155/2015/609593. Epub 2015 May 18.
2
Th1/Th2 cytokines in patients with Graves' disease with or without ophthalmopathy.伴有或不伴有眼病的格雷夫斯病患者体内的Th1/Th2细胞因子
Iran J Allergy Asthma Immunol. 2013 May 15;12(2):168-75.
3
Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.格雷夫斯病患者血清促炎细胞因子浓度:治疗、甲状腺功能、眼病及吸烟的影响
Eur J Endocrinol. 2000 Aug;143(2):197-202. doi: 10.1530/eje.0.1430197.
4
Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.重度桥本氏病中Th1/Th2细胞比例升高以及难治性格雷夫斯病中Th17细胞比例升高。
Thyroid. 2009 May;19(5):495-501. doi: 10.1089/thy.2008.0423.
5
Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).Th1和Th2血清细胞因子谱可区分桥本甲状腺炎患者(Th1型)和格雷夫斯病患者(Th2型)。
Neuroimmunomodulation. 2004;11(4):209-13. doi: 10.1159/000078438.
6
TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.促甲状腺激素受体腺病毒诱导的格雷夫斯甲亢在干扰素-γ和白细胞介素-4基因敲除小鼠中均有所减轻;对Th1/Th2模式的启示。
Clin Exp Immunol. 2004 Dec;138(3):417-22. doi: 10.1111/j.1365-2249.2004.02641.x.
7
The potential markers involved in newly diagnosed graves' disease and the development of active graves' orbitopathy.新诊断的格雷夫斯病和活动性格雷夫斯眼病发展中涉及的潜在标志物。
Cytokine. 2020 Mar;127:154998. doi: 10.1016/j.cyto.2020.154998. Epub 2020 Jan 20.
8
The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.甲巯咪唑治疗期间格雷夫斯病中Th1/Th2相关细胞因子IL-12/IL-5的平衡变化
Autoimmunity. 2007 Feb;40(1):31-7. doi: 10.1080/08916930601165388.
9
CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.CD4 + T细胞和Th1/Th2失衡与格雷夫斯眼病的发病机制有关。
Int J Mol Med. 2006 May;17(5):911-6.
10
Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves' Disease.Th17 细胞上 TIM-3 表达降低与 Graves 病患者眼病相关。
Curr Mol Med. 2018;18(2):83-90. doi: 10.2174/1566524018666180705105753.

引用本文的文献

1
Effect of methimazole treatment on Th1, Th17, and Th22 lymphocytes in pediatric Graves' disease patients.甲巯咪唑治疗对儿童格雷夫斯病患者 Th1、Th17 和 Th22 淋巴细胞的影响。
Front Immunol. 2024 Oct 3;15:1431686. doi: 10.3389/fimmu.2024.1431686. eCollection 2024.
2
Interaction of MMP-9 in the active phase of Graves' disease with and without ophthalmopathy.格雷夫斯病活动期伴或不伴眼病患者 MMP-9 的相互作用。
Am J Physiol Endocrinol Metab. 2024 Oct 1;327(4):E577-E584. doi: 10.1152/ajpendo.00166.2024. Epub 2024 Sep 11.
3
Immunological Processes in the Orbit and Indications for Current and Potential Drug Targets.眼眶中的免疫过程以及当前和潜在药物靶点的适应症
J Clin Med. 2023 Dec 22;13(1):72. doi: 10.3390/jcm13010072.
4
Assessment of the levels of interleukin-17 and interleukin-38 in thyroid-associated ophthalmopathy patients.评估甲状腺相关眼病患者白细胞介素-17 和白细胞介素-38 的水平。
Int Ophthalmol. 2023 Aug;43(8):2811-2824. doi: 10.1007/s10792-023-02679-1. Epub 2023 Mar 9.
5
Mechanisms of immune-related differentially expressed genes in thyroid-associated ophthalmopathy based on the GEO database.基于GEO数据库的甲状腺相关眼病中免疫相关差异表达基因的机制
Ann Transl Med. 2022 Sep;10(17):926. doi: 10.21037/atm-22-3470.
6
Novel inflammatory biomarkers in thyroid eye disease.甲状腺眼病的新型炎症生物标志物。
Eur J Endocrinol. 2022 Jun 29;187(2):293-300. doi: 10.1530/EJE-22-0247. Print 2022 Aug 1.
7
Thyroid eye disease: From pathogenesis to targeted therapies.甲状腺眼病:从发病机制到靶向治疗
Taiwan J Ophthalmol. 2022 Jan 21;12(1):3-11. doi: 10.4103/tjo.tjo_51_21. eCollection 2022 Jan-Mar.
8
2021 update on thyroid-associated ophthalmopathy.2021 年甲状腺相关眼病更新。
J Endocrinol Invest. 2022 Feb;45(2):235-259. doi: 10.1007/s40618-021-01663-9. Epub 2021 Aug 20.
9
Decreased serum levels of IL-27and IL-35 in patients with Graves disease.Graves 病患者血清中 IL-27 和 IL-35 水平降低。
Arch Endocrinol Metab. 2021 May 18;64(5):521-527. doi: 10.20945/2359-3997000000227.
10
Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy.甲状腺眼病中 T 细胞免疫的作用机制。
Front Endocrinol (Lausanne). 2021 Apr 1;12:648732. doi: 10.3389/fendo.2021.648732. eCollection 2021.

本文引用的文献

1
Correlation between serum RANTES levels and the severity of Parkinson's disease.血清 RANTES 水平与帕金森病严重程度的相关性。
Oxid Med Cell Longev. 2014;2014:208408. doi: 10.1155/2014/208408. Epub 2014 Dec 22.
2
Th17 cells in autoimmune and infectious diseases.自身免疫性疾病和感染性疾病中的Th17细胞
Int J Inflam. 2014;2014:651503. doi: 10.1155/2014/651503. Epub 2014 Aug 3.
3
Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves' ophthalmopathy.微小RNA-146a(miR-146a)和白细胞介素-17(IL-17)的循环水平与格雷夫斯眼病的临床活动度显著相关。
Endocr J. 2014;61(11):1087-92. doi: 10.1507/endocrj.ej14-0246. Epub 2014 Aug 7.
4
Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.甲状腺相关性眼病的分子发病机制的当前概念。
Invest Ophthalmol Vis Sci. 2014 Mar 20;55(3):1735-48. doi: 10.1167/iovs.14-14002.
5
Th17 cells in immunity and autoimmunity.免疫与自身免疫中的辅助性T细胞17
Clin Dev Immunol. 2013;2013:986789. doi: 10.1155/2013/986789. Epub 2013 Dec 26.
6
Diagnosis and classification of Graves' disease.Graves 病的诊断和分类。
Autoimmun Rev. 2014 Apr-May;13(4-5):398-402. doi: 10.1016/j.autrev.2014.01.013. Epub 2014 Jan 12.
7
Diagnosis and management of Graves disease: a global overview.Graves 病的诊断与治疗:全球视角
Nat Rev Endocrinol. 2013 Dec;9(12):724-34. doi: 10.1038/nrendo.2013.193. Epub 2013 Oct 15.
8
Th1/Th2 cytokines in patients with Graves' disease with or without ophthalmopathy.伴有或不伴有眼病的格雷夫斯病患者体内的Th1/Th2细胞因子
Iran J Allergy Asthma Immunol. 2013 May 15;12(2):168-75.
9
Cytokine levels in the serum of healthy subjects.健康受试者血清中的细胞因子水平。
Mediators Inflamm. 2013;2013:434010. doi: 10.1155/2013/434010. Epub 2013 Mar 7.
10
Increased serum interleukin-17 in Graves' ophthalmopathy.Graves 眼病患者血清白细胞介素-17 水平升高。
Graefes Arch Clin Exp Ophthalmol. 2012 Oct;250(10):1521-6. doi: 10.1007/s00417-012-2092-7. Epub 2012 Jul 1.